While considerable groundbreaking cancer research related to EGFR and its mutations is based on research in lung cancer patients [4, 27], breast cancer is also known to be strongly associated with EGFR stimulated cell growth [28–31]. This evidence concerns the gene EGFR and lung carcinoma.